+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Multicenter double-blind, randomized study on neoral vs sandimmune in heart transplantation One year results



Multicenter double-blind, randomized study on neoral vs sandimmune in heart transplantation One year results



Journal of Heart & Lung Transplantation 18(1): 93




(PDF emailed within 1 workday: $29.90)

Accession: 035349761

Download citation: RISBibTeXText


Related references

NOF-11: a one-year randomized double-blind comparison of Neoral versus Sandimmune in pediatric liver transplantation. Transplantation Proceedings 30(5): 1961-1961, 1998

NOF-11: a one-year pediatric randomized double-blind comparison of neoral versus sandimmune in orthotopic liver transplantation. Transplantation 69(1): 87-92, 2000

A randomized double-blind comparison of neoral vs sandimmune for pediatric liver transplantation-the first four weeks. Journal of Investigative Medicine 45(1): 161A, 1997

A comparative randomized prospective multicenter study of Sandimmune vs Neoral in liver transplantation. Annales de Chirurgie 52(8): 716-721, 1998

Superior graft survival in a long term double-blind study of neoral and sandimmune for renal transplantation. Journal of the American Society of Nephrology 9(PROGRAM AND ABSTR ISSUE): 699A, Sept, 1997

Neoral conversion study: shift from Sandimmune classic formulation to Sandimmune Neoral in heart and lung transplant patients. Transplantation Proceedings 27(6): 3477-3477, 1995

Two year results of a double-blind, randomized, multicenter, international study of microemulsion vs oil-based cyclosporine in de novo heart transplant patients. Circulation 100(18 SUPPL ): I 391, Nov 2, 1999

Three year results of the double-blind randomized multicenter trial of mycophenolate mofetil in heart transplant patients. Journal of Heart & Lung Transplantation 18(1): 53, 1999

A double-blind randomized study of Sandimmun Neoral versus Sandimmun in new renal transplant recipients: results after 12 months. The International Sandimmun Neoral Study Group. Transplantation Proceedings 27(2): 1849-1856, 1995

One-year Results of the Effects of Rituximab on Acute Antibody-Mediated Rejection in Renal Transplantation: RITUX ERAH, a Multicenter Double-blind Randomized Placebo-controlled Trial. Transplantation 100(2): 391-399, 2016

Addition of isradipine results in a better renal function after kidney transplantation A double-blind, randomized, placebo-controlled, multicenter study. Journal of the American Society of Nephrology 10(PROGRAM AND ABSTR ISSUE): 750A, Sept, 1999

An open randomized parallel group study to compare Sandimmune Neoral with Sandimmune soft gelatin capsule in stable renal transplant patients. Transplantation Proceedings 28(3): 1202-1203, 1996

Acute and long-term effects of pimobendan (UD-CG 115) in NYHA II and III heart failure. Results of a randomized multicenter double-blind study. Zeitschrift für Kardiologie 80(11): 687-694, 1991

24-Month safety results of a randomized, multicenter, double-blind study of everolimus vs azathioprine in de novo heart transplant recipients. Journal of Heart & Lung Transplantation 23(2S): S45, February, 2004

A multicenter, prospective, randomized, double-blind trial of basiliximab in heart transplantation. Journal of Heart and Lung Transplantation 24(9): 1297-1304, 2005